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Abstract: Dilated cardiomyopathy (DCM) is among the most common cardiac diseases in dogs. Its
pathogenesis is not fully understood, but myocardial remodeling and inflammation are suspected to be
involved. The present study aimed to characterize the pathological processes in canine DCM, investi-
gating morphological changes in association with the expression of relevant cytokines and remodeling
markers. The myocardium of 17 dogs with DCM and 6 dogs without cardiac diseases was histologically
evaluated, and selected cases were further examined by immunohistochemistry, morphometry, and reverse
transcription quantitative PCR. In DCM, the myocardium exhibited subtle but statistically significant
diffuse quantitative changes. These comprised increased interstitial collagen deposition and macrophage
numbers, as well as an overall reduced proportion of contractile tissue. This was accompanied by a sig-
nificant increase in myocardial transcription of intracellular adhesion molecule (ICAM) 1, inflammatory
cytokines, and remodeling enzymes. Laser microdissection showed that cardiomyocytes transcribed most
relevant markers including ICAM-1, tumor necrosis factor ฀, transforming growth factor ฀ (TGF-฀), ma-
trix metalloproteinase 2 (MMP-2), tissue inhibitor of MMP (TIMP) 1 and TIMP-2. In addition, there
were multifocal cell-rich lesions characterized by fibrosis, neovascularization, macrophage infiltration, and
cardiomyocyte degeneration. In these, macrophages were often found to express ICAM-1, TGF-฀, and
vascular endothelial growth factor; the former two were also expressed by cardiomyocytes. These results
characterize the diffuse myocardial remodeling processes that occur in DCM. The observed multifocal
cell-rich lesions might result from reduced tissue perfusion. Macrophages and cardiomyocytes seem to
actively contribute to the remodeling processes, which ultimately lead to cardiac dilation and dysfunc-
tion. The precise role of the involved cells and the factors initiating the remodeling process still needs to
be identified.
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Abstract
Dilated cardiomyopathy (DCM) is among the most common cardiac diseases in dogs. Its pathogenesis is not fully understood, but
myocardial remodeling and inflammation are suspected to be involved. The present study aimed to characterize the pathological
processes in canine DCM, investigating morphological changes in association with the expression of relevant cytokines and
remodeling markers. The myocardium of 17 dogs with DCM and 6 dogs without cardiac diseases was histologically evaluated, and
selected cases were further examined by immunohistochemistry, morphometry, and reverse transcription quantitative PCR. In
DCM, the myocardium exhibited subtle but statistically significant diffuse quantitative changes. These comprised increased
interstitial collagen deposition and macrophage numbers, as well as an overall reduced proportion of contractile tissue. This was
accompanied by a significant increase in myocardial transcription of intracellular adhesion molecule (ICAM) 1, inflammatory
cytokines, and remodeling enzymes. Laser microdissection showed that cardiomyocytes transcribed most relevant markers
including ICAM-1, tumor necrosis factor a, transforming growth factor b (TGF-b), matrix metalloproteinase 2 (MMP-2), tissue
inhibitor of MMP (TIMP) 1 and TIMP-2. In addition, there were multifocal cell-rich lesions characterized by fibrosis, neovascu-
larization, macrophage infiltration, and cardiomyocyte degeneration. In these, macrophages were often found to express ICAM-1,
TGF-b, and vascular endothelial growth factor; the former two were also expressed by cardiomyocytes. These results char-
acterize the diffuse myocardial remodeling processes that occur in DCM. The observed multifocal cell-rich lesions might result
from reduced tissue perfusion. Macrophages and cardiomyocytes seem to actively contribute to the remodeling processes, which
ultimately lead to cardiac dilation and dysfunction. The precise role of the involved cells and the factors initiating the remodeling
process still needs to be identified.
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Dilated cardiomyopathy (DCM) is the most common cardiac
disease in large-breed dogs and is characterized by cardiac cham-
ber dilation, systolic dysfunction, and, in some cases, ventricular
arrhythmia, which is eventually followed by congestive heart
failure and/or sudden death.38,48,52,56 The clinical diagnosis of
DCM is based on echocardiographic findings and excluding other
cardiac or systemic diseases and medications such as treatment
with anthracycline34 that may induce similar changes.11,38,48,52
Gross postmortem examination of the canine DCM heart
reveals eccentric, primarily left ventricular hypertrophy and
secondary left atrial dilation.11,52 The histological changes,
however, appear not to be very specific and are usually
reported as mild: variation in myocyte size, myocyte degenera-
tion and necrosis, and myocardial fibrosis of variable extent
have been described.4,13,28,43,55 According to the literature, 1 of
2 distinct histological patterns can predominate depending on
the affected dog breed. The “fatty infiltration-degenerative”
type, with myofiber degeneration, fibrosis, and adipocyte infil-
tration, is mainly described in Boxers and Doberman
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Pinschers.53 The “attenuated wavy fiber” type, with myofiber
atrophy and a long wavy appearance of fibers, is typical of
DCM in giant breeds but may also occur in Boxers and Dober-
man Pinschers.53 More recent studies described further myo-
cardial alterations, such as a change in the cardiomyocyte
phenotype (reduced desmin expression), an increase in
vimentin-positive cells in the left atrium, a mild mononuclear
inflammatory infiltration in the interstitium of both atria and
ventricular free walls,27,28 and hypertrophy of coronary vessel
walls.29
Progress has also been made regarding the etiology of DCM,
and genes associated with the disease have been identified in
Boxers, Doberman Pinschers, and Irish Wolfhounds.39,40,42,48
Following numerous studies conducted on small and large
experimental animal models of both cardiomyopathies and
myocardial infarction,7,8,24 it is generally accepted that most
pathological processes affecting the myocardium, including
DCM, result in a sequence of structural and functional changes
known as myocardial remodeling.8,47 Myocardial remodeling
is in general prompted by cardiomyocyte injury, followed by an
inflammatory reaction that is mediated by different cell types,
including neutrophils, macrophages, and lymphocytes, and
regulated by several factors: proinflammatory cytokines,
adhesion molecules, and extracellular matrix–degrading
enzymes (eg, matrix metalloproteinases [MMPs]).1,18,47
Anti-inflammatory cytokines and growth factors such as
transforming growth factor b (TGF-b) are subsequently
involved in the reparative phase, promoting differentiation
of fibroblasts into myofibroblasts and extracellular matrix
deposition.5,9,18,19 However, this repair process can also result
in excessive fibrosis.18 Although sharing common pathways,
depending on the type and extent of the initiating injury,
different cellular and extracellular components are involved,
and the outcome may vary.3,47
Recent studies by our group confirmed increased myocar-
dial transcription of inflammatory cytokines, MMPs, and their
inhibitors in dogs with cardiac diseases, suggesting a general
activation of inflammatory responses in the myocardium in
association with cardiac diseases.15,16
We hypothesized that the inflammatory and remodeling pro-
cesses that are postulated to occur in the myocardium in asso-
ciation with canine DCM have consistent histopathological
correlates in addition to those changes described so far. There-
fore, the aim of the present study was to thoroughly assess the
myocardium of dogs with clinically and grossly confirmed
DCM for any pathological features and potential quantitative
changes, to gain further information on the pathomechanisms
underlying DCM.
Materials and Methods
Animals and Sample Collection
The study was conducted on the hearts of 23 dogs: 17 dogs with
DCM and 6 dogs with diseases not involving the heart (control
group) (Suppl. Tables S1 and S2). The dogs were all
euthanized, except for dog No. 1.16, which suffered sudden
death on a walk. Among the 17 dogs with DCM were 10 Great
Danes, 6 Doberman Pinschers, and 1 Bullmastiff; they had a
mean age of 6.4 years (range, 4–10 years). Nine dogs were
female (4 of these were neutered) and 8 were male (of which
1 was neutered). The dogs in the control group represented
various breeds and had a mean age of 7 years (range, 0.5–11
years), with 3 males and 3 females neutered.
At different time points prior to death, echocardiography
had been carried out in all dogs with DCM to diagnose the
disease, except for dog No. 1.16. For this dog, DCM was diag-
nosed on gross and histological cardiac findings during full
necropsy. Further clinical investigations of the dogs with DCM
had been performed at the discretion of the attending clinician
(a board-certified cardiologist or a cardiology resident under
direct supervision of a board-certified cardiologist) and
included a complete blood count, biochemistry, electrocardio-
graphy, and/or thoracic radiographs, depending on patient pre-
sentation. Dogs with noncardiac diseases were euthanized on
request of the owners due to grave prognoses (Suppl. Table S2).
These dogs underwent investigations according to their presen-
tation and based on the assessment of the attending clinician.
Dogs underwent a partial (thoracic cavity) diagnostic post-
mortem examination with the owners’ consent. Hearts were
removed and grossly examined for any pathological changes.
Samples were collected from left atrium (LA) and right atrium
(RA), left ventricular free wall (LV), right ventricular free wall
(RV), and interventricular septum (IVS) for histological exam-
ination and, in selected cases (4 DCM and all control dogs), for
RNA extraction (Suppl. Tables S1 and S2). For the latter, to
obtain samples of the atria, these were opened and 3 to 4
samples of around 3 to 5 mm in length were collected from
the central part of the LA and RA and placed in RNAlater
(Thermo Fisher, Waltham, MA). For the ventricular samples,
the lower half of the heart was separated by a cross section, and
2 to 3 samples of around 5 mm length in each direction (if the
LV was thicker than 5 mm, a thinner slice was taken to ensure
saturation with RNAlater) was obtained from each of the mid-
dle LV, IVS, and RV myocardium toward the heart base and
placed in RNAlater. For histology, LA and RA were laminated
vertically to produce ring-shaped cross sections that allowed
dorsoventral orientation of the specimens in the cassette. One
cross-sectional slice of the removed apex was processed, and
longitudinal sections were prepared from the lateral quadrant of
the LV and RV, including the atrioventricular valves and ven-
tricular papillary muscles. Samples of the IVS were taken from
the center, between heart base and apex, stretching from the
anterior epicardium to the middle of the IVS muscle.
Histological, Immunohistochemical, and Fluorescence
Examinations
Myocardial samples were fixed in 10% neutral-buffered for-
malin and routinely embedded in paraffin wax. Consecutive
sections (3–5 mm) were prepared and routinely stained with
hematoxylin and eosin and the van Gieson (VG) stain for the
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demonstration of collagen. In 15 DCM cases (Suppl. Table S1)
and all control hearts, additional sections were subjected to
immunohistochemistry and fluorescence staining.
The specimens were evaluated by light microscopy and
assessed for any histopathological changes, including those
previously described in DCM, such as fatty infiltration, wavy
fibers, fibrosis, and cardiomyocyte necrosis/degeneration.53
Immunohistochemistry was performed using a Dako auto-
stainer (Dako, Glostrup, Denmark) or the Discovery XT auto-
stainer (Ventana Medical System, Tucson, AZ) to detect
leukocytes (CD18þ, Major Histocompatibility Complex
(MHC) IIþ), specifically, T cells (CD3þ), B cells (CD20þ),
macrophages (calprotectinþ, CD18þ, Iba-1þ), blood vessels
(ie, vascular endothelial cells [factor VIIIþ, CD31þ]) and
smooth muscle cells (a–smooth muscle actin [a-SMA]þ), and
relevant mediators (ie, TGF-b1, vascular endothelial growth
factor [VEGF] and its receptor [Flk-1] and intercellular adhe-
sion molecule 1 [ICAM-1]). Immunohistochemistry methods
are listed in Supplemental Table S3. Briefly, after deparaffina-
tion, antigen retrieval was performed for all antigens except for
a-SMA and CD20, by incubation of the slides with citrate
buffer (pH 6) at 98C for 10 minutes or with EDTA buffer
(pH 9) at 98C for 20 minutes. Endogenous peroxidase was
blocked by incubation with hydrogen peroxide solution for 10
minutes. Sections were incubated with horse serum for 30 min-
utes at room temperature, followed by the primary antibodies
and matching secondary antibodies; different detection kits
were then applied. Sections were washed with phosphate-
buffered saline between each incubation step (pH 8). Finally,
sections were counterstained with hematoxylin for 40 seconds
and mounted.
Consecutive sections incubated with an isotype-matched
irrelevant antibody or without the primary antibody served as
negative controls. A chronic inflammatory process with gran-
ulation tissue formation served as positive control tissue.
The immunohistochemical staining was evaluated based on
the morphology and location of the positive cells (vascular
endothelial cells, smooth muscle cells in vessel wall, interstitial
cells, lymphocytes, and cardiomyocytes) as well as their dis-
tribution (scattered, multifocal, or diffuse).
A further section underwent fluorescence staining to mark
cell nuclei, using the ProLong Diamond Antifade Mountant
with DAPI (40,6-diamidino-2-phenylindole; Invitrogen, Carls-
bad, CA). Briefly, after deparaffination and rehydration, sec-
tions were incubated with DAPI for 24 hours at room
temperature in the dark and then mounted.
Histomorphometric Analysis
Sections from RV, LV, and IVS from 15 dogs with DCM
(Suppl. Table S1) and from all control dogs (Suppl. Table S2)
that were stained with the VG stain, DAPI fluorescence, and
immunohistochemistry for a-SMA and Iba-1 and exhibited con-
sistent staining quality throughout the entire section were
scanned (NanoZoomer-XR C12000; Hamamatsu, Hamamatsu
City, Japan) to obtain high-resolution digital images. These
were subsequently analyzed with the Visiopharm Integrator
System (VIS, version 4.5.1.324; Visiopharm, Hørsholm, Den-
mark), considering the following parameters: overall cell num-
ber (based on the number of DAPI-positive nuclei), percentage
area occupied by collagen fibers (based on the percentage of
VG-positive fibers), number of interstitial macrophages and
blood vessels (based on the number of Iba-1- and a-SMA-
positive cells, respectively), and the respective proportion of
tissue occupied by (a) cardiomyocytes (interpreted as contrac-
tile tissue), (b) collagen fibers, and (c) fiber- and cell-free
interstitial space (all assessed in the VG-stained section). To
specify, for each section, regions of interest with a size of 0.237
mm2 (the area of a high-power field with 1 ocular of 22 mm
field of view) were randomly selected across the myocardium
from areas free of focal cell-rich lesions. For DAPI, a-SMA
and Iba-1, and VG, positive cells and percentage of VG-
positive fibers were counted in 20 regions of interest per sec-
tion. In the VG-stained sections, the areas composed of (a)
cardiomyocytes, (b) collagen fibers, and (c) fiber- and cell-
free interstitial space were quantified within 10 regions of
interest per section.
Relative Quantification of Cytokine and Remodeling
Marker Transcription
From selected DCM cases (Nos. 1.10, 1.11, 1.14, and 1.15;
Suppl. Table S1) and the control dogs (which were partly used
in previous studies15,16), myocardial samples were collected
within 1 hour after death. These were stored in RNAlater at –
20C until further use. Reverse transcriptase quantitative
polymerase chain reaction (RT-qPCR) was carried out as pre-
viously described.17 Published primer sequences were used for
the canine housekeeping gene GAPDH; ICAM-1; cytokines
(interleukin [IL]–1, IL-6, IL-8, IL-10; tumor necrosis factor
a [TNF-a]; TGF-b); MMP–1, MMP-2, MMP-3, MMP-9, and
MMP-13; tissue inhibitor of MMP (TIMP)–1, TIMP-2, TIMP-
3, and TIMP-4; and lysyl oxidase.15,16,41 As previously
reported, the primer efficiencies were between 95% and
118%.15,16 The relative transcription levels of all markers were
calculated using GAPDH and the 2–DCt method, as previously
reported; all dogs have been part of previous studies, the results
of which have been published in different contexts.15,16 From 1
dog with DCM (dog No. 1.10), cardiomyocytes were collected
using laser microdissection; RNA was extracted and qPCR was
carried out as previously reported.15,16
Statistical Analyses
Statistical analysis was carried out using SPSS (SPSS, Inc, an
IBM Company, Chicago, IL). Distribution of data obtained
from histomorphometry and qPCR was analyzed applying gra-
phical Q-Q plots and Kolmogorov-Smirnov and Shapiro-Wilk
tests. Data were not normally distributed for a-SMA, VG,
ICAM-1, cytokines, MMP, and TIMPs. Results from dogs with
DCM and control dogs and results for different cardiac regions
were therefore compared using Kruskal-Wallis and Mann-
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Whitney U tests for nonnormally distributed data and 1-way
analysis of variance (ANOVA) and unpaired t tests for nor-




Dogs with DCM were Great Danes (n ¼ 10), Doberman
Pinschers (n ¼ 6), and 1 Bull Mastiff; the 6 control dogs were
all of different breeds. With a mean (SD) age of 6.4 (1.6) and 7
(3.6) years, respectively, dogs with DCM and control dogs
were of similar age (P ¼ .531). Among the dogs with DCM,
the Great Danes had a mean (SD) age of 6 (1.5) years and were
overall slightly younger than the Doberman Pinschers, which
had a mean (SD) age of 7 (1.8) years. However, the age dif-
ference was not significant (P ¼ .247).
Gross Findings
Grossly, the hearts from all dogs with DCM showed the previ-
ously reported macroscopic changes,11,52 that is, cardiomegaly
and chamber dilation (primarily of LA and LV). The hearts of
control dogs were macroscopically unremarkable.
The DCM Myocardium Exhibits Diffuse Widening of the
Interstitium With Increase in Collagen Deposition and
Macrophages and Relative Reduction of the Contractile
Tissue
All hearts were first screened for the presence of those
histological features of DCM that are known from the
literature.11,37,53 Changes consistent with the fatty
infiltration-degenerative type were disseminated in the LV
and/or IVS in 12 DCM cases (6/6 Doberman Pinschers, 5/10
Great Danes, 1/1 Bullmastiff) and also in the RA, RV, or LA in
half of the cases (n ¼ 6; 4 Doberman Pinschers, 1 Great Dane,
and the Bullmastiff). Changes consistent with the attenuated
wavy fiber type, represented by multifocal areas with thin myo-
fibers that showed a wavy appearance, were detected only in
Great Danes (7/10), most frequently in the RA (n ¼ 5), fol-
lowed by the RV (n ¼ 3) and LV and IVS (each n ¼ 2). The
results are listed in Supplemental Table S1. Neither change was
observed in the control hearts.
In 5 of 17 DCM dogs (4 Great Danes and 1 Doberman
Pinscher; dog Nos. 1.1, 1.2, 1.6, 1.10, 1.12), there were vascu-
lar changes represented by mild medial hypertrophy of intra-
mural arteries.13,29 A focal chronic mural thrombus was
detected in the LA of 1 Great Dane (dog No. 1.10).
In comparison to the myocardium of the control dogs, the
interstitium of the DCM myocardium appeared overall diffu-
sely wider and more cellular (Figs. 1, 2). In most cases, this
finding was most prominent in the LV and IVS. The interstitial
cells were generally round to spindle shaped, with a moderate
to high amount of cytoplasm and oval to round nuclei. Some
were more slender and resembled fibroblasts but did not appear
associated with collagen deposition (Fig. 3). Regardless of their
shape, the majority of these cells were identified as macro-
phages, as they were found to express Iba-1, CD18, and MHC
II (Fig. 4a–c). Occasional intact cardiomyocytes distant from
lesions exhibited strong cytoplasmic MHC II expression (data
not shown). Calprotectin expression was observed in mono-
cytes within vessel lumina and in occasional elongated inter-
stitial cells, suggesting these had recently emigrated from the
blood into the tissue.18 A small proportion of the spindle-
shaped cells showed a-SMA expression (Fig. 5a). Otherwise,
a-SMA-positive cells were seen to surround small blood ves-
sels, as confirmed by the matching arrangement of endothelial
cells (FVIII-related antigenþ; Fig. 5b); the latter were found to
occasionally express Iba-1 and MHC II (Fig. 4a,c). Occasional
individual T cells (CD3þ) and B cells (CD20þ) were also seen.
Apart from the above-mentioned occasional “wavy fibers”
and mild degenerative changes (rare loss of striation and scat-
tered cytoplasmic vacuolization), the cardiomyocytes appeared
unaltered.
A morphometric approach was taken to substantiate the
above findings. Assessment of the control dogs showed that
in all examined cardiac regions (ie, LV, RV, IVS), the myo-
cardium was similar with respect to the overall cellularity
(DAPIþ nuclei), proportion of contractile tissue, interstitial
width (optically empty space plus collagen fibers), and the
amount of small vessels (a-SMAþ vascular structures) and
macrophages (Iba-1þ) in the interstitium (Table 1).
In DCM, the myocardium exhibited an overall significantly
lower cellularity (DAPIþ nuclei) than in control dogs. This was
coupled with a significant increase in the number of Iba-1þ
interstitial macrophages and a significantly lower relative pro-
portion of contractile tissue, as well as an increased proportion
of both fiber- and cell-free interstitial space and interstitial
collagen (Table 2).
A comparison of these parameters in the different cardiac
regions (LV, RV, IVS) of dogs with DCM and control dogs
confirmed these results. The proportion of fiber- and cell-free
interstitial space was significantly increased and the proportion
of contractile tissue was significantly reduced in all 3 regions in
DCM dogs (Table 1). Similarly, DCM dogs also exhibited a
decreased overall cellularity and an increase in interstitial col-
lagen, but the difference was significant only in the LV and
IVS. Interestingly, the amount of Iba-1þ interstitial macro-
phages was increased in both LV and IVS, but the difference
was only significant in the LV (Table 1). A comparison of the
different cardiac regions in DCM also showed region-
dependent differences for several parameters. The number of
interstitial macrophages (Iba-1þ) was significantly higher in
the LV and IVS than in the RV. The interstitial collagen con-
tent was higher in the LV than in the IVS, whereas the propor-
tion of contractile tissue (area covered by cardiomyocytes) was
higher in the IVS than in the LV (Table 1).
There was no significant difference in the number of inter-
stitial vessels (a-SMAþ structures) between both groups of dogs
and in the different cardiac regions in both groups (Tables 1, 2).
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The DCM Myocardium Exhibits Focal Lesions,
Representing Areas of Fibroblast and Macrophage
Accumulation and New Vessel Formation
In 14 DCM cases, focal to multifocal, occasionally coalescing
lesions, ranging between approximately 0.1 and 5 mm in dia-
meter (Fig. 6a), were found in addition to the diffuse changes
described above. These consisted of focal expansion of the
interstitium and replacement of cardiomyocytes by cell-rich
infiltrates containing differentiated vessels and abundant round
to elongate cells with a morphology similar to the interstitial
cells described above (Fig. 6b). A large proportion of these
cells were identified as macrophages (Iba-1þ, CD18þ, MHC
IIþ) (Fig. 7a–c). However, staining for a-SMA revealed that
Figure 1. Control heart, dog No. 2.3. Unaltered myocardium with tightly aligned cardiomyocytes. Hematoxylin and eosin (HE). Figures 2–5.
Dilated cardiomyopathy, heart, dog No. 1.15. Figure 2. The myocardium exhibits a widened interstitium with an increased amount of cells
(arrow). HE. Figure 3. The interstitial cells (arrow) are round to spindle shaped, with an oval to round nucleus, sometimes more slender,
resembling fibroblasts. HE. Figure 4. The majority of interstitial cells are macrophages, as they express ionized calcium binding adaptor
molecule 1 (Iba-1) (a), CD18 (b), and Major Histocompatibility Complex (MHC) II (c). Occasional endothelial cells (arrowheads) in interstitial
vessels express Iba-1 (a) and/or MHC II (c). Immunohistochemistry, hematoxylin counterstain. Figure 5. The interstitium exhibits abundant
small vessels, identified by an outer layer of a–smooth muscle actin (a-SMA)–positive cells (smooth muscle cells, arrows) (a) and an inner FVIII-
related antigen-positive endothelial cell layer (b). A small proportion of the spindle-shaped cells in the interstitium also show a-SMA expression
(myofibroblasts; arrowheads) (a). Immunohistochemistry, hematoxylin counterstain.
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the infiltrates also contained large amounts of small vessels
(ranging in diameter between approximately 10 and 50 mm;
Fig. 7d). This was confirmed by staining for FVIII-related
antigen and CD31, both highlighting the inner ring of endothe-
lial cells and the presence of a small vascular lumen. The
endothelial cells were occasionally found to also express Iba-
1 (Fig. 7a) and MHC II (Fig. 7c). Vessels clearly dominated in
some areas of the lesions (Fig. 8). Collagen fibers were found in
small amounts between the cells within the lesions and repla-
cing or surrounding individual degenerated cardiomyocytes.
The fibers were generally thin and loosely arranged, rarely
forming more mature, dense fibrous tissue deposits (Fig. 9).
Residual cardiomyocytes entrapped within the lesions dis-
played degenerative changes (swollen and vacuolated sarco-
plasm) or necrosis. These lesions were most frequent in the
LV (12/17), IVS (6/17), and RA (5/17) (Suppl. Table S1). In
the control dogs, the myocardium did not exhibit any of the
above described histological changes.
The Pathological Changes in the DCM Myocardium Are
Associated With Significant Upregulation of Cytokines
and Remodeling Markers
As previously described, the normal canine myocardium exhi-
bits constitutive expression of cytokines and remodeling mar-
kers.15,16 In the present study, we showed that this is also true
for the adhesion molecule ICAM-1. In comparison, dogs with
DCM showed significantly higher myocardial transcription of
ICAM-1, TNF-a, IL-1, IL-8, IL-10, MMP-2, TIMP-1, and lysyl
oxidase (Table 3). Laser microdissection with subsequent
qPCR from 1 dog indicated that cardiomyocytes have gene
expression of all markers tested with this approach (ie,
ICAM-1, TNF-a, IL-8, TGF-b, MMP-2, TIMP-1, and TIMP-
2). For ICAM-1 and TGF-b, immunohistochemistry was also
applied and confirmed that morphologically unaltered cardio-













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2. Comparison of Overall Cellularity, Number of Interstitial
Small Vessels, and Macrophages, and Percentage of Area Covered by
Cardiomyocytes, Collagen, and Fiber- and Cell-Free Interstitial Space
in the Myocardium (Right and Left Ventricle and Interventricular
Septum) of Control Dogs and Dogs With DCM.a
Parameters Control (n ¼ 14) DCM (n ¼ 23) P Value
DAPI 1002 (268) 761 # (124) .003
a-SMA 920 (310–1066) 724 (434–1214) .72
Collagen 1.17 (0.15–2.03) 3.08 " (1.02–12.37) <.001
Iba-1 53.4 (23.1) 73.1 " (33.9) .038
Cardiomyocytes 88.9 (4.8) 67.3 # (10.2) <.001
Interstitial space 10.0 (4.4) 29.2 " (8.9) <.001
Abbreviations: a-SMA, a–smooth muscle actin; DAPI, 40 ,6-diamidino-2-
phenylindole; DCM, dilated cardiomyopathy; Iba-1, ionized calcium binding
adaptor molecule 1; IVS, interventricular septum; LV, left ventricle; RV, right
ventricle.
aOverall assessment based on the available data for all 3 cardiac regions.
Normal distributed results are reported as mean (standard deviation); not
normal distributed data are reported as median (interquartile range).
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(TGF-b) levels in control hearts, and moderately (ICAM-1) and
weakly (TGF-b) in DCM (Figs. 10–15). VEGF and its receptor,
Flk1, were not expressed in the myocardium of control dogs,
and VEGF expression was not detected in cardiomyocytes in
DCM either (Figs. 16, 17). However, Flk1 was consistently
expressed by cardiomyocytes in DCM (Figs. 18, 19). ICAM-
1, TGF-b, and VEGF were also expressed in a proportion of
cells within the focal lesions, mainly with the morphology of
macrophages (Figs. 12, 15, 17). Interestingly, the mononuclear
cells in the interstitium were often strongly TGF-b positive
(Fig. 14) but showed only weak ICAM-1 (Fig. 11) and neither
VEGF nor Flk1 expression (Figs. 16, 18). Endothelial cells of
Figures 6–9. Dilated cardiomyopathy, heart, dog No. 1.15. Focal lesions. Figure 6. (a) Focal replacement of cardiomyocytes by a cell-rich
infiltrate. M, myocardium with unaltered cardiomyocytes. (b) The infiltrate contains differentiated vessels (arrows) and abundant round to
elongate cells with a morphology similar to the interstitial cells that were observed in increased numbers throughout the entire myocardium.
Hematoxylin and eosin (HE). Figure 7. A large proportion of cells in the infiltrate are identified as macrophages, based on the expression of
ionized calcium binding adaptor molecule 1 (Iba-1) (a), CD18 (b), and major histocompatibility complex (MHC) II (c), intermingled with and
slightly outnumbering the a–smooth muscle actin (a-SMA)–positive cells that mainly form small vessels (d). Occasional endothelial cells also
express Iba-1 (a; arrowhead) and MHC II (c; arrowhead). Immunohistochemistry, hematoxylin counterstain. Figure 8. Vessels clearly dom-
inated in some areas of the lesions. Immunohistochemistry for a-SMA, hematoxylin counterstain. Figure 9. Small amounts of predominantly
thin and loosely arranged collagen (arrowheads) between the cells within the lesions. Van Gieson.
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both intralesional and extralesional vessels occasionally
showed weak ICAM-1, TGF-b, and Flk1 expression. A similar
expression was seen occasionally in vessels in the control
hearts.
Discussion
The present study represents a detailed investigation into the
pathological changes of canine DCM, a disease associated with
cardiac remodeling and of largely unknown pathogen-
esis.29,47,51 Our results confirm a number of previously
described histological changes as consistent features of canine
DCM.53 The so-called fatty infiltration-degenerative type was
primarily found in Doberman Pinschers and the Bullmastiff.53
These dogs did not show changes consistent with the attenuated
wavy fiber type. Great Danes, on the other hand, exhibited
either fatty infiltration-degenerative or attenuated wavy fiber
type changes, or both. Similar to previously published studies,
these results suggest breed-dependent differences in the under-
lying pathogenesis or in the cardiomyocyte response to
injury,54 which might also be the cause of breed differences
in clinical presentations.48,55 Interestingly, fatty infiltration-
degenerative type changes were found to affect both the left
and right heart, whereas attenuated wavy fiber type changes
were more prominent in the right (RA and RV); this differs
from a previous study undertaken in several dog breeds that
reported wavy fibers as most abundant in the LV.53
Besides these known morphological features, the present
study revealed more subtle diffuse myocardial changes in all
DCM hearts and, in addition, cell-rich focal lesions in a large
proportion of cases, both without any relation to the presence
of attenuated wavy fiber or fatty infiltration-degenerative
type changes. To specify, the diffuse changes consisted of
a relative reduction of the contractile tissue in association
with an expansion of the interstitium due to an overall widen-
ing of the fiber- and cell-free space and an increase in the
amount of interstitial collagen. Alongside this, an overall
significantly reduced cellularity was observed despite a sig-
nificant increase in interstitial macrophages (Iba1þ); this
indicates that DCM is associated with loss of cardiomyocytes
and thereby of contractile tissue.
Taken together, these findings point toward individual car-
diomyocyte injury and loss as the initial pathogenic process.
This suggests that canine DCM differs from human primary
DCM where the overall cell number does not change and an
increase in cardiac muscle mass is observed as a result of
compensatory cardiomyocyte hypertrophy.2 Further detailed
studies would be required to confirm that canine DCM is
indeed not associated with a change in cardiomyocyte size.
The focal cell-rich lesions were found more or less ran-
domly distributed in most (14/17) DCM hearts, where they
were most prevalent and intense in the LV, followed by the
IVS. Macrophages (Iba-1þ, CD18þ, MHC IIþ) were also abun-
dant in these lesions. Both here and in the interstitium, the
macrophages could be the result of local proliferation of resi-
dent cardiac macrophages and of monocyte recruitment.22,26
Since calprotectin, a myeloid cell marker expressed by neutro-
phils, monocytes, and recently blood-derived but not mature
macrophages,18 was found to be expressed only rarely in myo-
cardial macrophages, it is likely that the vast majority were
tissue-resident macrophages or resulted from local prolifera-
tion of macrophages recruited at an earlier stage.32 Given the
large heterogeneity of macrophage phenotypes and func-
tions,12,20,23 it is not clear if macrophages involved in the
response to cardiac injury have a proinflammatory role and
contribute to adverse cardiac remodeling or have instead a
reparative and cardioprotective function.12,19,26 It has been pos-
tulated that resident macrophages are more likely to have a role
in tissue repair processes in cardiac injury.12 However, in the
present study, immunohistochemistry showed that macro-
phages in the focal lesions expressed TGF-b, ICAM-1, VEGF,
and, less abundantly, its receptor Flk1. These findings suggest a
dual function (ie. both a reparative and an inflammatory role) in
canine DCM. In rats, ICAM-1, a cell adhesion molecule critical
for leukocyte recruitment, mediates adhesion of macrophages
to cardiomyocytes.6,44 Such macrophage adherence can result
in decreased cardiomyocyte contractility via the expression of
TNF-a, oxygen free radicals, and nitric oxide.44 Laser micro-
dissection with subsequent qPCR undertaken on the myocar-
dium of 1 dog and immunohistochemistry provide strong
evidence that cardiomyocytes produce ICAM-1, cytokines, and
Table 3. Relative Messenger RNA Expression of ICAM-1, Cytokines,
and Remodeling Markers in the Myocardium of Control Dogs and
Dogs With DCM.a
Marker Control (n ¼ 30b) DCM (n ¼ 20b) P Value
ICAM 298 (107–761) 1277 " (255–3934) .003
IL-1 7.6 (4.5–23.8) 19.4 " (11.7–32.3) .012
IL-6 10.02 (3.23–24.2) 71.3 (6.97–144) .075
IL-8 47.2 (26.1–119.4) 232 " (71.6–811) .001
IL-10 19.5 (12.8–38.3) 48.7 " (32.1–153) <.001
TNF-a 4.14 (2.75–6.83) 12.4 " (3.05–19.6) .019
TGF-b 3457 (1977–4960) 3555 (2622–4780) .406
MMP-1 1.97 (0.3–10.9) 2.49 (0.2–21.2) .621
MMP-2 230 (52.4–386.2) 980 " (318.6–2033.4) <.001
MMP-3 0.11 (0.0–1.7) 0.12 (0.0–0.53) .338
MMP-9 9.1 (1.5–28.6) 3.4 (1.6–61.6) .890
MMP-13 0.64 (0.18–1.41) 1.37 (0.75–3.88) .053
TIMP-1 401 (229–1212) 1173 " (513–7563) .002
TIMP-2 6801 (4783–9615) 10510 (5516–18408) .055
TIMP-3 18655 (6910–27788) 11735 (5071–20188) .075
TIMP-4 1777 (1325–3478) 3347 (1609–4878) .175
Lysyl oxidase 889 (403–1805) 1795 " (1078–3252) .009
Abbreviations: DCM, dilated cardiomyopathy; ICAM, intercellular adhesion
molecule 1; IL, interleukin; MMP, matrix metalloproteinase; TGF, transforming
growth factor; TIMP, tissue inhibitor of metalloproteinases; TNF, tumor
necrosis factor.
aRelative expression using the Ct value of the respective marker to the Ct
value of GAPDH was applied, 2–DCt. Results are reported as median
(interquartile range).
bTotal number of samples (left atrium, right atrium, left ventricle,
interventricular septum, and right ventricle) examined for this group. P values
indicating significant differences are in bold.
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remodeling enzymes, such as IL-8, TNF-a, TGF-b, MMP-2,
TIMP-1, and TIMP-2. This suggests that both macrophages and
cardiomyocytes might contribute to cardiomyocyte damage
and/or dysfunction and the pathogenic process in dogs with
DCM. ICAM-1 and cytokine upregulation also suggest an
inflammatory state of the DCM myocardium. Inflammatory
cytokines, such as TNF-a and IL-1, and chemokines regulate
collagen turnover. These cytokines are involved in the dysre-
gulation of MMP and TIMP expression8,10 and inhibition of
collagen degradation. This contributes to fibrosis, as observed
in the dogs with DCM, and to decreased myocardial contrac-
tility and progression of heart failure, as reported for human
DCM.31,46,47 In particular, upregulation of MMP-2, TIMP-1,
and TIMP-2 has been described in nonischemic human DCM
and in experimental conditions in dogs,35,36,45,51 which is sim-
ilar to the increase of MMP-2 and TIMP-1 found in the DCM
dogs. Furthermore, TGF-b that was expressed by cardiomyo-
cytes as well as by lesional and interstitial macrophages might
contribute to the increase in collagen observed in the DCM
dogs. Cardiomyocytes under stress conditions or undergoing
necrosis are known to be able to contribute to fibrosis through
the production of TGF-b.21 TGF-b exerts profibrotic effects
through the proliferation and differentiation of fibroblasts into
myofibroblasts,5,9,10 cells that were likely present both among
the interstitial macrophage population and within the focal cell-
rich lesions in the canine DCM myocardium.
In addition to the macrophage infiltration, the focal cell-
rich lesions exhibited abundant small vessels indicative of
neovascularization, whereas collagen deposition was limited.
Individual degenerating/necrotic cardiomyocytes were found
in the periphery of or entrapped within the lesions. The mor-
phological evidence of neovascularization was associated
with VEGF expression within infiltrating cells (most likely
macrophages) in the lesions. These macrophages also produce
TGF-b,25,54 which, next to hypoxia, further stimulates VEGF
production.25,50
Interestingly, the macrophages with higher proangiogenic
potential have been shown to belong to the anti-inflammatory
subset of macrophages and might therefore be involved in a
repair attempt of the observed lesions.30
Figures 10–12. Expression of intracellular adhesion molecule 1 (ICAM-1) in the myocardium. Immunohistochemistry, hematoxylin counter-
stain. Figure 10. Control heart, dog No. 2.2. Cardiomyocytes show weak ICAM-1 expression. Inset: No reaction is seen in a negative control
slide. Figures 11 and 12. Dilated cardiomyopathy (DCM), heart, dog No. 1.15. Figure 11. Cardiomyocytes show moderate ICAM-1
expression. The interstitial cells exhibit only very weak staining (arrowheads). Figure 12. A substantial proportion of the mononuclear cells
in the focal lesion exhibit ICAM-1 expression (arrowheads). Arrows: cardiomyocytes. Figures 13–15. Expression of transforming growth
factor b (TGF-b) in the myocardium. Immunohistochemistry, hematoxylin counterstain. Figure 13. Control heart, dog No. 2.1. Cardiomyo-
cytes show no or very weak TGF-b expression. Figures 14–15. DCM, heart, dog No. 1.15. Figure 14. Cardiomyocytes exhibit very weak to
weak TGF-b expression, whereas the interstitial cells are often strongly TGF-b-positive (arrowheads). Figure 15. A substantial proportion of
the mononuclear cells in the focal lesion exhibit ICAM expression (inset: arrowheads). Arrows: cardiomyocytes.
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We found evidence of substantial expression of the VEGF
receptor Flk-1 by cardiomyocytes in DCM, with particular
intensity in cardiomyocytes entrapped in the lesions. When
binding to Flk-1, VEGF exerts its angiogenetic properties; this
interaction might have further contributed to the observed new
vessel formation.50 Morphologically, the focal lesions resem-
ble chronic myocardial infarcts:14 infarct healing is associated,
particularly in the dog, with an intense angiogenic response.7
Considering that we did not observe changes that would
directly explain these lesions, and taking into account the
described diffuse changes, it appears most likely that the focal
lesions are a consequence of focal cardiomyocyte necrosis as a
result of reduced tissue perfusion. The latter might be the result
of the increased distance between blood vessels and cardiomyo-
cytes due to interstitial edema (indicated by the overall widening
of the interstitial space) and collagen deposition, or it might also
derive from the reduced oxygen tension characteristic of the
microenvironment of a chronically inflamed tissue.49
In summary, canine DCM is associated with diffuse myo-
cardial remodeling processes and focal lesions in the majority
of dogs. Both macrophages and cardiomyocytes might actively
contribute to the pathogenic process through the production of
cytokines, adhesion molecules, and remodeling enzymes,
which eventually leads to cardiac dilation and impaired cardiac
function.
Interestingly, we found similar changes (ie, generalized dif-
fuse remodeling and focal lesions) with cardiomyocyte degen-
eration, increased fibrosis, macrophages, and neovascularization
in cats with hypertrophic cardiomyopathy, a disease with a very
different phenotype.33 The resemblance of these results suggests
similar pathophysiological processes. Further investigations are
required to explain how these processes result in diseases with
different structural and functional presentations and which are
the roles of macrophages and cardiomyocytes, since both appear
primarily involved in the pathogenesis of both canine DCM and
feline hypertrophic cardiomyopathy.
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48. Stephenson HM, Fonfara S, López-Alvarez J, et al. Screening for dilated car-
diomyopathy in Great Danes in the United Kingdom. J Vet Intern Med. 2012;
26(5):1140–1147.
49. Szade A, Grochot-Przeczek A, Florczyk U, et al. Cellular and molecular
mechanisms of inflammation-induced angiogenesis. IUBMB Life. 2015;67(3):
145–159.
50. Taimeh Z, Loughran J, Birks EJ, et al. Vascular endothelial growth factor in
heart failure. Nat Rev Cardiol. 2013;10(9):519–530.
51. Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase
activity and selective upregulation in LV myocardium from patients with end-
stage dilated cardiomyopathy. Circulation. 1998;97(17):1708–1715.
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